昊帆生物
(301393)
| 流通市值：11.95亿 | | | 总市值：52.20亿 |
| 流通股本：2472.75万 | | | 总股本：1.08亿 |
| 报告期 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 1,734,899,973.95 | 1,739,510,856.63 | 1,631,206,757.39 | 55,410,954.21 |
| 应收票据及应收账款 | 74,828,576.82 | 62,123,018.41 | 67,166,667.92 | 74,048,783.55 |
| 其中：应收票据 | 1,471,780 | 1,764,531 | 1,917,545.02 | 4,598,125.02 |
| 应收账款 | 73,356,796.82 | 60,358,487.41 | 65,249,122.9 | 69,450,658.53 |
| 应收款项融资 | 1,044,164 | 1,437,600 | 6,412,870 | 4,385,850 |
| 预付款项 | 9,863,619.9 | 5,315,962.13 | 17,261,104.62 | 6,367,171.8 |
| 其他应收款合计 | 390,848.02 | 493,431.57 | 973,671.66 | 711,252.64 |
| 存货 | 110,170,011.11 | 114,997,735.93 | 119,200,124.51 | 124,419,563.36 |
| 其他流动资产 | 8,192,006.66 | 9,371,950.28 | 11,273,821.28 | 12,716,788.56 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 1,981,489,807.37 | 1,964,007,891.97 | 1,961,912,269.39 | 343,060,364.12 |
| 非流动资产: | | | | |
| 固定资产 | 210,802,224.95 | 212,347,028.17 | 213,540,987.04 | 118,821,563.61 |
| 在建工程 | 81,582,803.2 | 72,449,763.57 | 40,466,426.95 | 104,802,764.48 |
| 使用权资产 | 1,348,296.34 | 1,660,956.72 | 572,745.39 | 894,900.38 |
| 无形资产 | 23,874,150.59 | 24,017,610.68 | 24,161,070.77 | 24,304,530.86 |
| 长期待摊费用 | 55,260.96 | 79,117.68 | 153,099.73 | 178,584.3 |
| 递延所得税资产 | 4,694,861.1 | 3,664,805.86 | 2,566,063.36 | 2,713,193.5 |
| 其他非流动资产 | 8,302,048.67 | 8,714,764.63 | 31,483,859.62 | 43,357,314.24 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 330,659,645.81 | 322,934,047.31 | 312,944,252.86 | 295,072,851.37 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 2,312,149,453.18 | 2,286,941,939.28 | 2,274,856,522.25 | 638,133,215.49 |
| 流动负债: | | | | |
| 应付票据及应付账款 | 51,673,523.12 | 44,521,964.05 | 51,127,083 | 71,606,753.51 |
| 其中：应付票据 | 16,926,620 | 10,520,200 | 4,166,000 | 30,012,954.09 |
| 应付账款 | 34,746,903.12 | 34,001,764.05 | 46,961,083 | 41,593,799.42 |
| 合同负债 | 2,110,133.63 | 613,356.81 | 4,634,702.12 | 409,902.53 |
| 应付职工薪酬 | 6,269,738.5 | 12,790,610.38 | 11,069,684.81 | 6,098,404.99 |
| 应交税费 | 7,903,130.11 | 4,665,674.34 | 4,320,285.93 | 4,524,420.28 |
| 其他应付款合计 | 504,693.12 | 568,232.79 | 613,871.52 | 533,732.56 |
| 一年内到期的非流动负债 | 714,049.11 | 831,338.38 | 299,811.16 | 510,437.06 |
| 其他流动负债 | 1,389,687.17 | 1,844,317.11 | 2,357,517.53 | 3,363,053.56 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 70,564,954.76 | 65,835,493.86 | 74,422,956.07 | 87,046,704.49 |
| 非流动负债: | | | | |
| 租赁负债 | 663,590.52 | 724,964.01 | - | - |
| 递延收益 | 8,270,204.17 | 8,451,816.67 | 8,633,429.2 | 8,838,266.67 |
| 递延所得税负债 | 107,044.76 | 65,345.37 | 552,712.84 | 107,900.37 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 9,040,839.45 | 9,242,126.05 | 9,186,142.04 | 8,946,167.04 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 79,605,794.21 | 75,077,619.91 | 83,609,098.11 | 95,992,871.53 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 108,000,000 | 108,000,000 | 108,000,000 | 81,000,000 |
| 资本公积 | 1,683,177,029.98 | 1,683,177,029.98 | 1,683,177,029.98 | 54,788,300.53 |
| 减:库存股 | 9,434,008.5 | - | - | - |
| 专项储备 | 3,278,384.62 | 2,993,876.26 | 2,450,831.7 | 1,894,730.22 |
| 盈余公积 | 46,490,080.64 | 44,660,697.77 | 39,716,529.21 | 39,716,529.21 |
| 未分配利润 | 401,032,172.23 | 373,032,715.36 | 357,903,033.25 | 364,740,784 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 2,232,543,658.97 | 2,211,864,319.37 | 2,191,247,424.14 | 542,140,343.96 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 2,232,543,658.97 | 2,211,864,319.37 | 2,191,247,424.14 | 542,140,343.96 |
| 负债和股东权益合计 | 2,312,149,453.18 | 2,286,941,939.28 | 2,274,856,522.25 | 638,133,215.49 |
| 公告日期 | 2024-04-26 | 2024-04-09 | 2023-10-25 | 2023-08-18 |
| 审计意见(境内) | | 标准无保留意见 | | |